MedPath

ADRIAMYCIN RDF

ADRIAMYCIN RDF

Discontinued
DIN Number

02069563

Drug Class

Human

Market Date

Dec 31, 1996

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02069563
AIG Number0110825004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01DB01 DOXORUBICIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DOXORUBICIN HYDROCHLORIDEActive
Strength: 150 MG / VIAL
Monograph: DOXORUBICIN HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.